• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G-CSF 动员的单倍体供者移植物中的 NK 细胞和PMN-MDSC 显示出与未动员供者移植物不同的基因表达谱。

NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart.

机构信息

Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Department of Pediatric Hematology/Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

出版信息

Front Immunol. 2021 Apr 27;12:657329. doi: 10.3389/fimmu.2021.657329. eCollection 2021.

DOI:10.3389/fimmu.2021.657329
PMID:33986748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111072/
Abstract

A recent approach of hematopoietic stem cell (HSC) transplantation from haploidentical donors "mobilized" with G-CSF is based on the selective depletion of T and B lymphocytes from the graft. Through this approach, the patient receives both HSC and mature donor-derived effector cells (including NK cells), which exert both anti-leukemia activity and protection against infections. We previously showed that donor HSC mobilization with G-CSF results in accumulation in the graft of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), capable of inhibiting the anti-leukemia activity of allogeneic NK cells. Here, we performed a detailed gene expression analysis on NK cells and PMN-MDSCs both derived from mobilized graft. Cytotoxicity assays and real time PCR arrays were performed in NK cells. Microarray technology followed by bioinformatics analysis was used for gene expression profiling in PMN-MDSCs. Results indicate that NK cells from the graft have a lower cytolytic activity as compared to those from non-mobilized samples. Further, mobilized PMN-MDSCs displayed a peculiar transcriptional profile distinguishing them from non-mobilized ones. Differential expression of pro-proliferative and immune-modulatory genes was detected in mobilized PMN-MDSCs. These data strengthen the concept that G-CSF-mobilized PMN-MDSCs present in the graft display unique molecular characteristics, in line with the strong inhibitory effect on donor NK cells.

摘要

最近,一种来自用 G-CSF“动员”的单倍体供体的造血干细胞 (HSC) 移植方法是基于从移植物中选择性耗尽 T 和 B 淋巴细胞。通过这种方法,患者既接受 HSC,也接受成熟的供体衍生效应细胞(包括 NK 细胞),这些细胞既具有抗白血病活性,又能预防感染。我们之前表明,用 G-CSF 动员供体 HSC 会导致移植物中积累多形核髓系来源的抑制细胞 (PMN-MDSCs),这些细胞能够抑制同种异体 NK 细胞的抗白血病活性。在这里,我们对来自动员移植物的 NK 细胞和 PMN-MDSCs 进行了详细的基因表达分析。在 NK 细胞中进行了细胞毒性测定和实时 PCR 阵列分析。使用微阵列技术和生物信息学分析对 PMN-MDSCs 进行基因表达谱分析。结果表明,与非动员样本相比,移植物中的 NK 细胞的细胞毒性活性较低。此外,动员的 PMN-MDSCs 表现出独特的转录谱,将其与非动员的 PMN-MDSCs 区分开来。在动员的 PMN-MDSCs 中检测到促增殖和免疫调节基因的差异表达。这些数据进一步证实了 G-CSF 动员的 PMN-MDSCs 在移植物中显示出独特的分子特征,与对供体 NK 细胞的强烈抑制作用一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/709dcefe81b6/fimmu-12-657329-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/b06b7a80af9e/fimmu-12-657329-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/cf587cdd8126/fimmu-12-657329-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/6dd0edf4f9fd/fimmu-12-657329-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/41e3eeb7b63a/fimmu-12-657329-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/709dcefe81b6/fimmu-12-657329-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/b06b7a80af9e/fimmu-12-657329-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/cf587cdd8126/fimmu-12-657329-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/6dd0edf4f9fd/fimmu-12-657329-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/41e3eeb7b63a/fimmu-12-657329-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f46d/8111072/709dcefe81b6/fimmu-12-657329-g005.jpg

相似文献

1
NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart.G-CSF 动员的单倍体供者移植物中的 NK 细胞和PMN-MDSC 显示出与未动员供者移植物不同的基因表达谱。
Front Immunol. 2021 Apr 27;12:657329. doi: 10.3389/fimmu.2021.657329. eCollection 2021.
2
Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.聚乙二醇化粒细胞集落刺激因子动员的异基因造血干细胞移植通过在移植物中富集单核细胞来源的髓系抑制细胞改善严重急性移植物抗宿主病:真实世界经验。
Front Immunol. 2021 Apr 12;12:621935. doi: 10.3389/fimmu.2021.621935. eCollection 2021.
3
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.白细胞介素-2联合粒细胞集落刺激因子用于动员接受大剂量化疗的晚期乳腺癌患者祖细胞的初步试验:干细胞移植物内免疫效应细胞的扩增及干细胞输注后情况
J Clin Oncol. 2001 Feb 1;19(3):634-44. doi: 10.1200/JCO.2001.19.3.634.
4
Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.粒细胞集落刺激因子可有效动员 TCR γδ 和 NK 细胞,为异基因造血干细胞移植提供潜在增强移植物抗白血病效应的同种异体移植物。
Front Immunol. 2021 Mar 10;12:625165. doi: 10.3389/fimmu.2021.625165. eCollection 2021.
5
The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical allogeneic hematopoietic cell transplantation.在单倍体相合异基因造血细胞移植中,聚乙二醇化粒细胞集落刺激因子动员的造血干细胞的移植效果可能优于粒细胞集落刺激因子动员的造血干细胞。
Curr Res Transl Med. 2024 Dec;72(4):103473. doi: 10.1016/j.retram.2024.103473. Epub 2024 Sep 20.
6
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.对于急性白血病患者,GVHD 无复发生存率优于 G-BM 到 G-PBSC 移植物,这与同种异体移植中更高的髓系抑制细胞含量有关。
J Hematol Oncol. 2017 Jul 4;10(1):135. doi: 10.1186/s13045-017-0503-2.
7
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.中性粒细胞髓系来源抑制细胞在癌症患者外周血中大量存在,并抑制自然杀伤细胞的抗肿瘤活性。
Front Immunol. 2022 Jan 18;12:803014. doi: 10.3389/fimmu.2021.803014. eCollection 2021.
8
Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.蜕膜衍生粒细胞巨噬细胞集落刺激因子诱导循环 CD15+中性粒细胞中的多形核髓系来源抑制细胞。
Hum Reprod. 2020 Dec 1;35(12):2677-2691. doi: 10.1093/humrep/deaa217.
9
Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.移植物中单核细胞来源的髓系抑制细胞含量可预测粒细胞集落刺激因子动员的外周血干细胞异体移植后急性移植物抗宿主病的风险。
Biol Blood Marrow Transplant. 2014 Dec;20(12):2049-55. doi: 10.1016/j.bbmt.2014.09.011. Epub 2014 Sep 20.
10
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.使用普乐沙福动员健康供体影响T细胞受体(TCR)-αβ/CD19去除的单倍体同基因干细胞移植物的细胞组成。
J Transl Med. 2014 Sep 2;12:240. doi: 10.1186/s12967-014-0240-z.

引用本文的文献

1
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review).肿瘤相关中性粒细胞:癌症进展和治疗耐药性的关键调节因子(综述)
Int J Oncol. 2025 Apr;66(4). doi: 10.3892/ijo.2025.5734. Epub 2025 Feb 28.
2
Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy.粒细胞集落刺激因子动员外周血单个核细胞:嵌合抗原受体治疗的另一种细胞来源。
Int J Mol Sci. 2024 May 25;25(11):5769. doi: 10.3390/ijms25115769.
3
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors.

本文引用的文献

1
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation.肿瘤中的髓源性抑制细胞:从机制到抗原特异性和微环境调节。
Front Immunol. 2020 Jul 22;11:1371. doi: 10.3389/fimmu.2020.01371. eCollection 2020.
2
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.结核病和艾滋病的治疗方法:聚焦髓源性抑制细胞。
J Clin Invest. 2020 Jun 1;130(6):2789-2799. doi: 10.1172/JCI136288.
3
Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis.
表面 CD52、CD84 和 PTGER2 标记来自癌症患者和 G-CSF 处理供体的成熟 PMN-MDSC。
Cell Rep Med. 2024 Feb 20;5(2):101380. doi: 10.1016/j.xcrm.2023.101380. Epub 2024 Jan 18.
4
Myeloid-derived suppressor cells and pulmonary hypertension.髓系来源的抑制细胞与肺动脉高压。
Front Immunol. 2023 Jun 7;14:1189195. doi: 10.3389/fimmu.2023.1189195. eCollection 2023.
5
NK cells direct the perspective approaches to cancer immunotherapy.自然杀伤细胞指导癌症免疫治疗的方法。
Med Oncol. 2023 Jun 15;40(7):206. doi: 10.1007/s12032-023-02066-x.
6
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies.髓源性抑制细胞对血液系统恶性肿瘤中T细胞功能的调节作用
Front Cell Dev Biol. 2023 Apr 5;11:1129343. doi: 10.3389/fcell.2023.1129343. eCollection 2023.
7
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin.血液系统恶性肿瘤中的髓源性抑制细胞:硬币的两面。
Exp Hematol Oncol. 2022 Jul 19;11(1):43. doi: 10.1186/s40164-022-00296-9.
8
Decoding lymphomyeloid divergence and immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq.通过单细胞RNA测序解析G-CSF预处理的人骨髓中的淋巴细胞-髓细胞分化及免疫低反应性
Cell Discov. 2022 Jun 22;8(1):59. doi: 10.1038/s41421-022-00417-y.
9
IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells.IL-1R8 沉默可增强新鲜分离的人 NK 细胞的抗肿瘤功能。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003858.
10
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.中性粒细胞髓系来源抑制细胞在癌症患者外周血中大量存在,并抑制自然杀伤细胞的抗肿瘤活性。
Front Immunol. 2022 Jan 18;12:803014. doi: 10.3389/fimmu.2021.803014. eCollection 2021.
髓系来源的抑制性细胞功能和表观遗传表达在手术后脓毒症中随时间演变。
Crit Care. 2019 Nov 13;23(1):355. doi: 10.1186/s13054-019-2628-x.
4
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation.多形核髓系来源抑制细胞是单倍体造血干细胞移植中挽救自然杀伤细胞移植物抗白血病活性的新靶点。
Leukemia. 2020 Mar;34(3):932-937. doi: 10.1038/s41375-019-0585-7. Epub 2019 Oct 4.
5
The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.巨噬细胞四跨膜蛋白 4A4A 增强了依赖 Dectin-1 的 NK 细胞介导的转移抵抗能力。
Nat Immunol. 2019 Aug;20(8):1012-1022. doi: 10.1038/s41590-019-0417-y. Epub 2019 Jul 1.
6
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing.人细胞毒性自然杀伤细胞:一种新型非病毒方法,可实现高效转染和强烈杀伤肿瘤细胞。
Front Immunol. 2019 Apr 30;10:957. doi: 10.3389/fimmu.2019.00957. eCollection 2019.
7
Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias.人 γδ T 细胞:从表面受体到高危白血病的治疗。
Front Immunol. 2018 May 7;9:984. doi: 10.3389/fimmu.2018.00984. eCollection 2018.
8
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.如何测量 MDSC 的免疫抑制活性:检测方法、问题及潜在解决方案。
Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21.
9
Myeloid-derived suppressor cells coming of age.髓系来源的抑制细胞崭露头角。
Nat Immunol. 2018 Feb;19(2):108-119. doi: 10.1038/s41590-017-0022-x. Epub 2018 Jan 18.
10
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.髓源性抑制细胞:抑制抗肿瘤免疫的免疫抑制细胞,其受到微环境的影响。
J Immunol. 2018 Jan 15;200(2):422-431. doi: 10.4049/jimmunol.1701019.